Janux Therapeutics, Inc. (JANX) Misses Q1 EPS by 1c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Twilio (TWLO) call put ratio 1 call to 3.7 puts with a focus on October 290 and 295 puts as share price down 6.3%
• Trump on China: we will be speaking a lot